Close
Digital Health & Ai Innovation summit 2026
Medica Compamed 2026

ERT Delivers Actionable Insights to Identify COVID related Clinical Trial Risks

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Norton Healthcare Launches $30 Million High-Tech...

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across...

OSF HealthCare is expanding its deployment of advanced stroke...

Innovaccer and Mastek Form Strategic Healthcare...

Innovaccer and Mastek have announced a strategic healthcare AI...

Intuitive COVID-19 Dashboard highlights patient compliance risks to protect study outcomes

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, announced new reporting capabilities that help clinical trial sponsors and CROs ensure high-quality data collection during current global stay-home mandates. The newly launched COVID-19 Dashboard integrates data on coronavirus infection rates in geographic areas surrounding study investigative sites, so sponsors can identify and proactively intervene where patient and site compliance to study protocols may be at risk.

In order to get high-quality data that demonstrates their compoundโ€™s efficacy and safety, sponsors need to ensure patients are completing self-reported assessments as directed by the study protocol. When patient compliance drops, data quality suffers, which puts clinical development programs at risk. Because of current pandemic-related restrictions limiting in-person patient access to investigative sites, the risk of patient non-compliance increases. To mitigate this risk, clinical trial sponsors need robust, easy-to-access tools to identify protocol compliance risks before they cause data quality problems.

ERTโ€™s COVID-19 Dashboard helps sponsors identify areas of imminent risk caused by reduced patient site visits, enabling them to intervene and keep patients engaged throughout clinical trials. The dashboard presents convenient views of COVID-19 cases in relation to study site locations, flags sites and patients with potential device/data risks, and enables a targeted intervention approach toward real-time study monitoring to ensure data quality, regardless of patient access to investigative sites.

โ€œWith the COVID-19 Dashboard, sponsors donโ€™t have to waste time searching multiple sources to identify data collection, correction, and transmission issues that could negatively impact data quality,โ€ said Otis Johnson, Ph.D., Vice President of Trial Oversight at ERT. โ€œOur proprietary cloud-based data management and analytics platform enables us to quickly deliver actionable insights and put important information at our customersโ€™ fingertips so they can easily identify problem areas and take action to maintain the integrity of their studies.โ€

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Norton Healthcare Launches $30 Million High-Tech Automated Pharmacy Hub

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across 18 Hospitals to Speed Stroke Care

OSF HealthCare is expanding its deployment of advanced stroke...

Innovaccer and Mastek Form Strategic Healthcare AI Partnership

Innovaccer and Mastek have announced a strategic healthcare AI...

Chinese Researchers Develop OneGenome Genomic AI System for Rare Disease Diagnosis

Chinese researchers have introduced an open-source genomic AI system...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป